Kathleen S. Wright Associates’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-133
Closed -$7K 179
2022
Q4
$7K Hold
133
﹤0.01% 162
2022
Q3
$6K Sell
133
-33
-20% -$1.79K ﹤0.01% 150
2022
Q2
$9K Sell
166
-125
-43% -$8.06K 0.01% 128
2022
Q1
$20K Hold
291
0.01% 124
2021
Q4
$23K Buy
+291
New +$24.3K 0.02% 118

Other funds holding ENOV

Kathleen S. Wright Associates's ENOV Position: Q1 2023 in Review

Kathleen S. Wright Associates sold out of Enovis (ENOV) in Q1 2023, closing a stake of 133 shares — an estimated $7K sold.

Kathleen S. Wright Associates first reported a position in ENOV in Q4 2021 and held it in 5 quarters. The position peaked at $23K in Q4 2021. 249 funds tracked by Wall St. Rank hold ENOV as of Q1 2023.

  • Kathleen S. Wright Associates reported no remaining Enovis position as of Q1 2023 after selling out during the quarter.
  • Kathleen S. Wright Associates sold 133 Enovis shares in Q1 2023, an estimated $7K.
  • Kathleen S. Wright Associates first reported a position in Enovis in Q4 2021 and held it in 5 quarters.
  • Kathleen S. Wright Associates's Enovis position peaked at $23K in Q4 2021.
  • 249 funds tracked by Wall St. Rank held Enovis as of Q1 2023.

Based on Kathleen S. Wright Associates's 13F filing for Q1 2023, filed 21 Apr 2023.